Cargando…

A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice

In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in alpha-emitter-based peptide receptor radionuclide therapy (α-PRRT). Quantitative pharmacokinetic analyses of the in vivo alpha particle generator and its radioactive decay products are required to ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaid, Nouran R. R., Kletting, Peter, Winter, Gordon, Prasad, Vikas, Beer, Ambros J., Glatting, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703774/ https://www.ncbi.nlm.nih.gov/pubmed/34959413 http://dx.doi.org/10.3390/pharmaceutics13122132

Ejemplares similares

Physiologically Based Pharmacokinetic Modeling Is Essential in (90)Y-Labeled Anti-CD66 Radioimmunotherapy
por: Kletting, Peter, et al.
Publicado: (2015)

A population-based method to determine the time-integrated activity in molecular radiotherapy
por: Hardiansyah, Deni, et al.
Publicado: (2021)

Influence of sampling schedules on [(177)Lu]Lu-PSMA dosimetry
por: Rinscheid, Andreas, et al.
Publicado: (2020)

Optimization of Radiolabeling of a [(90)Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation
por: Winter, Gordon, et al.
Publicado: (2023)

The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model
por: Begum, Nusrat J., et al.
Publicado: (2019)

Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for (177)Lu-Labeled PSMA-Targeting Peptides
por: Kletting, Peter, et al.
Publicado: (2016)

Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
por: Meyer, Catherine, et al.
Publicado: (2022)

Multi-Modal PET and MR Imaging in the Hen’s Egg Test-Chorioallantoic Membrane (HET-CAM) Model for Initial In Vivo Testing of Target-Specific Radioligands
por: Winter, Gordon, et al.
Publicado: (2020)

Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept
por: Hardiansyah, Deni, et al.
Publicado: (2023)

Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model
por: Hardiansyah, Deni, et al.
Publicado: (2022)

Blocking Studies to Evaluate Receptor-Specific Radioligand Binding in the CAM Model by PET and MR Imaging
por: Löffler, Jessica, et al.
Publicado: (2022)

Quantitative analysis of regional distribution of tau pathology with (11)C-PBB3-PET in a clinical setting
por: Yousefzadeh-Nowshahr, Elham, et al.
Publicado: (2022)

Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule
por: Maaß, Christian, et al.
Publicado: (2016)

Comparison of Quantification of Target-Specific Accumulation of [(18)F]F-siPSMA-14 in the HET-CAM Model and in Mice Using PET/MRI
por: Löffler, Jessica, et al.
Publicado: (2021)

Targeted alpha-particle therapy in neuroendocrine neoplasms: A systematic review
por: Koh, Thuan Tzen, et al.
Publicado: (2021)

Preclinical PET and MR Evaluation of (89)Zr- and (68)Ga-Labeled Nanodiamonds in Mice over Different Time Scales
por: Winter, Gordon, et al.
Publicado: (2022)

Physiologically Based Pharmacokinetic (PBPK) Model for Biodistribution of Radiolabeled Peptides in Patients with Neuroendocrine Tumours
por: Gospavic, Radovan, et al.
Publicado: (2016)

Can Met-PET/CT Predict Sporadic Multiglandular Hyperparathyroidism? Report of a Case and Review of the Literature
por: Hillenbrand, Andreas, et al.
Publicado: (2019)

Analysis of Time-Dependent Pharmacokinetics Using In Vitro–In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
por: Kim, Min-Chang, et al.
Publicado: (2022)

A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of (68)Ga-DOTATATE in patients without neuroendocrine tumors
por: Siebinga, H., et al.
Publicado: (2021)

The First Physiologically Based Pharmacokinetic (PBPK) Model for an Oral Vaccine Using Alpha-Tocopherol as an Adjuvant
por: Saldanha, Leonor, et al.
Publicado: (2023)

In Vitro Release and In Vivo Pharmacokinetics of Praziquantel Loaded in Different Polymer Particles
por: Pereira, Emiliane Daher, et al.
Publicado: (2023)

mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
por: Exner, Samantha, et al.
Publicado: (2021)

Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha
por: Rycroft, Daniel, et al.
Publicado: (2015)

MEGen: A Physiologically Based Pharmacokinetic Model Generator
por: Loizou, George, et al.
Publicado: (2011)

Changes of Radiation Treatment Concept Based on (68)Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy
por: Bottke, Dirk, et al.
Publicado: (2021)

Short-Interval, Low-Dose Peptide Receptor Radionuclide Therapy in Combination with PD-1 Checkpoint Immunotherapy Induces Remission in Immunocompromised Patients with Metastatic Merkel Cell Carcinoma
por: Aicher, Alexandra, et al.
Publicado: (2022)

Correction: Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha
Publicado: (2015)

The Power of $\alpha$:: Electron Elementary Particle Generation with $\alpha$-quantized Lifetimes and Masses
por: MacGregor, Malcolm H
Publicado: (2007)

Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates
por: Herring, Brendon, et al.
Publicado: (2021)

Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators
por: Kozempel, Ján, et al.
Publicado: (2018)

Interobserver variability, detection rate, and lesion patterns of (68)Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy
por: Miksch, Jonathan, et al.
Publicado: (2020)

Physiologic and pharmacokinetic changes in pregnancy
por: Costantine, Maged M.
Publicado: (2014)

Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre
por: Thaiss, Wolfgang, et al.
Publicado: (2023)

Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
por: Exner, Samantha, et al.
Publicado: (2018)

Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
por: Berton, Mattia, et al.
Publicado: (2022)

Charged particle spectra in alpha.alpha and alpha.p collisions at the CERN ISR
por: Bell, W, et al.
Publicado: (1984)

Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation
por: Yoon, Miyoung, et al.
Publicado: (2016)

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
por: Murata, Yukiko, et al.
Publicado: (2022)

Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
por: Yamazaki, Shinji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gb0e3ia68omfs2i2r43mo02tpd